Solventum Corp reported 492M in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Abbott USD 6.95B 419M Jun/2025
Align Technology USD 873.01M 170.88M Mar/2025
Baxter International USD 2.29B 530M Mar/2025
Becton, Dickinson and Co. USD 735M 68M Jun/2025
Cencora USD 2.23B 992.41M Jun/2025
Dexcom USD 1.16B 254.1M Jun/2025
Insulet USD 1.12B 107M Jun/2025
Solventum Corp 492M 42M Jun/2025
West Pharmaceutical Services USD 509.7M 105.5M Jun/2025
Zimmer Biomet Holdings USD 556.9M 827.6M Jun/2025